StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.59+0.15 (+10.42%)

Close on Nov 17, 2026Market cap $6.18MP/E –Yield –

Quantum Biopharma r&d expenses

Research and development expenses are spending on new products and technology.

Quantum Biopharma's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.58M, down 78.1% year over year. For fiscal 2025 it was $2.76M, down 54.6% from the year before. The highest annual figure on record is $7.83M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.76M-54.6%
FY2024Dec 31, 2024$6.08M+57.6%
FY2023Dec 31, 2023$3.86M-44.2%
FY2022Dec 31, 2022$6.91M+9.2%
FY2021Dec 31, 2021$6.33M-19.2%
FY2020Dec 31, 2020$7.83M–
FY2019Dec 31, 2019$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$387.43K-29.5%
Q1 FY2026Mar 31, 2026$626.09K-62.0%
Q4 FY2025Dec 31, 2025$70.40K-98.4%
Q3 FY2025Sep 30, 2025$495.22K-33.5%
Q2 FY2025Jun 30, 2025$549.20K-38.8%
Q1 FY2025Mar 31, 2025$1.65M+928.5%
Q4 FY2024Dec 31, 2024$4.28M+12876.6%
Q3 FY2024Sep 30, 2024$744.80K-53.8%
Q2 FY2024Jun 30, 2024$897.99K–
Q1 FY2024Mar 31, 2024$160.26K–
Q3 FY2023Sep 30, 2023$32.99K–
Q2 FY2023Jun 30, 2023$1.61M–

More Quantum Biopharma figures

See a number that looks wrong?